| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Lite Strategy, Inc. (LITS) has 7 insiders with recent SEC Form 4 filings, including 1 buy and 0 sells. LITS is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 3.67M | $3.51M | - | |
| CEO | 635.0K | $606.7K | - | |
| Dir | 100.0K | $95.5K | - | |
| Dir | 55.0K | $52.5K | - | |
| Dir | 55.0K | $52.5K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 21, 2015 | Baltic Charles V. III | Director | Buy | 5,000 | $3.81 | $19,050.00 | +26.0% |